๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Stage II-III Non-small Cell Lung Cancer

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy NCT05398094Phase 220 sites๐Ÿ“ Alicante๐Ÿ“ Badalona๐Ÿ“ Barcelona Fundaciรณn GECP ยท Tests: Sotorasib A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer NCT07082179Phase 21 site๐Ÿ“ Nanjing Jiangsu Cancer Institute & Hospital ยท Tests: Iparomlimab and Tuvonralimab combined with paclitaxel polymer micelles and Platinum (cisplatin/carboplatin) RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC NCT07541521n/a10 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen Shanghai Chest Hospital ยท Tests: Robot-assisted thoracoscopic surgery (RATS) sleeve lobectomy Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC NCT03872661Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: IBI308, Bevacizumab, Pemetrexed, Carboplatin, Thoracic surgery Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation NCT07012031Phase 1, Phase 29 sites๐Ÿ“ Sacramento๐Ÿ“ Tampa๐Ÿ“ Tampa National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC) NCT04302025Phase 238 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ Los Angeles Genentech, Inc. ยท Tests: Alectinib, Entrectinib, Vemurafenib, Cobimetinib, Pralsetinib Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer NCT07251582Phase 32 sites๐Ÿ“ Changsha๐Ÿ“ Changsha Hunan Province Tumor Hospital ยท Tests: Time of Day-based Assignment for Infusion of Immune Checkpoint Inhibitor (e.g., toripalimab, or pembrolizumab) + platinโ€ฆ Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC) NCT07153445Phase 221 sites๐Ÿ“ Alicante๐Ÿ“ Badalona๐Ÿ“ Barcelona Fundaciรณn GECP ยท Tests: Atezolizumab, Paclitaxel, Carboplatin Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma NCT07314216Phase 21 site๐Ÿ“ Changsha Hunan Cancer Hospital ยท Tests: Firmonertinib, Definitive Thoracic Radiotherapy Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) NCT06437977Phase 31 site๐Ÿ“ Shanghai Shanghai Chest Hospital ยท Tests: SBRT, Toripalimab A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer NCT05913089Phase 210 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ยท Tests: TQB2450 injection + Chemotherapy, TQB2450 injection + Anlotinib Hydrochloride Capsule SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations NCT06080776Phase 31 site๐Ÿ“ Shanghai Nanjing Sanhome Pharmaceutical, Co., Ltd. ยท Tests: SH-1028 tablets, Placebo SH-1028 tablets The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer NCT05502523NA4 sites๐Ÿ“ Abington๐Ÿ“ Philadelphia๐Ÿ“ Philadelphia Thomas Jefferson University ยท Tests: Pulmonary Artery-First Surgical Technique, Biospecimen Collection PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study NCT06945484NA2 sites๐Ÿ“ Galveston๐Ÿ“ Salt Lake City University of Utah ยท Tests: Precision Exercise Regimen for Cancer Care (PERCC) A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer NCT06122064NA1 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Best Practice, Communication Intervention, Electronic Health Record Review, Survey Administration, Video Recording Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) NCT04585477Phase 21 site๐Ÿ“ Stanford Stanford University ยท Tests: AVENIO ctDNA Surveillance Kit, Durvalumab, Durvalumab (Imfinzi) alone or in combination with platinum-based chemotherapy Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC Harboring Atypical EGFR Mutations NCT07336732Phase 21 site๐Ÿ“ Guangzhou Avistone Biotechnology Co., Ltd. ยท Tests: PLB1004 Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer NCT06656598Phase 225 sites๐Ÿ“ Angers๐Ÿ“ Angers๐Ÿ“ Avignon Intergroupe Francophone de Cancerologie Thoracique ยท Tests: Carboplatin, Paclitaxel, Cemiplimab, Curative hypofractionated radiotherapy, Cemiplimab (maintenance) Concomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer NCT07489391NA2 sites๐Ÿ“ Barcelona๐Ÿ“ Pamplona University of Deusto ยท Tests: Multimodal exercise Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer NCT07410975Phase 21 site๐Ÿ“ Shanghai Shanghai Pulmonary Hospital, Shanghai, China ยท Tests: sintilimab+IBI310+chemotherapy Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer NCT05136846Phase 12 sites๐Ÿ“ Duarte๐Ÿ“ Columbus Ohio State University Comprehensive Cancer Center ยท Tests: Carboplatin, Durvalumab, Paclitaxel, Papaverine, Radiation Therapy Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC NCT06939127Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Neoadjuvant Cryoablation Combined with Tislelizumab and Chemotherapy, Surgery, Adjuvant tislelizumab Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC NCT06709859Phase 21 site๐Ÿ“ Jinan Shandong Public Health Clinical Center ยท Tests: Afatinib plus chemotherapy as conversion treatment A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. NCT06284317Phase 342 sites๐Ÿ“ Camperdown๐Ÿ“ Penrith๐Ÿ“ St Leonards ETOP IBCSG Partners Foundation ยท Tests: Adjuvant durvalumab Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC NCT06552234Phase 220 sites๐Ÿ“ Aix-en-Provence๐Ÿ“ Marseille๐Ÿ“ Toulon Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer ยท Tests: Repotrectinib Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab NCT05568212Phase 21 site๐Ÿ“ Roma Fondazione Ricerca Traslazionale ยท Tests: Durvalumab, Olaparib tablet, Single-agent chemotherapy, Platinum doublet chemotherapy Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC NCT07554846Phase 31 site๐Ÿ“ Shanghai Fudan University ยท Tests: Peroperative immunotherapy, Neoadjuvant immunotherapy, Adjuvant immunotherapy Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers NCT03948100NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Educational Intervention, Quality-of-Life Assessment, Questionnaire Administration, Yoga IBI363 (PD-1/IL-2ฮฑ-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer NCT07408635Phase 21 site๐Ÿ“ Shanghai Shanghai Pulmonary Hospital, Shanghai, China ยท Tests: IBI363 + Chemotherapy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy